REQUEST A DEMO
Total
USD $0.00
Search more companies

Idaman Pharma Manufacturing Sdn. Bhd. (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Idaman Pharma Manufacturing Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Idaman Pharma Manufacturing Sdn. Bhd. is a company in Malaysia, with a head office in Sungai Petani. It operates in the Pharmaceutical and Medicine Manufacturing industry. Idaman Pharma Manufacturing Sdn. Bhd. was incorporated on August 06, 2004. The latest financial highlights indicate a net sales revenue drop of 2.11% in 2023. Its total assets grew by 0.37% over the same period. The net profit margin of Idaman Pharma Manufacturing Sdn. Bhd. decreased by 6.12% in 2023.

Headquarters
Lot 24 & 25, Jalan Perusahaan Lapan, Bakar Arang Industrial Estate
Sungai Petani; Kedah; Postal Code: 08000

Contact Details: Purchase the Idaman Pharma Manufacturing Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Idaman Pharma Manufacturing Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Idaman Pharma Manufacturing Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Idaman Pharma Manufacturing Sdn. Bhd. report to view the information.
Incorporation Date:
August 06, 2004
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Idaman Pharma Manufacturing Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-2.11%
Total operating revenue
-2.11%
Operating profit (EBIT)
-53.28%
Net Profit (Loss) for the Period
-63.14%
Total assets
0.37%
Total equity
17.43%
Operating Profit Margin (ROS)
-7.84%
Net Profit Margin
-6.12%
Return on Equity (ROE)
-11.05%
Quick Ratio
0.19%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?